Bayer used illegal and anti-competitive practices to monopolize the U.S. market for genetically engineered corn seeds, reaping "hundreds of millions, if not ​billions, of ill-gotten dollars," ...

As many as eight Barcelona players have been included in Spain’s squad for the upcoming FIFA World Cup that does not included a single player from 15-time European champions Real Madrid for the first ...

LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer is pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the ...

Bayer's proposed $7.25 billion Roundup settlement is facing its first formal objections, after attorneys for 13 cancer ...

Bayer BAYN-1.22%decrease; red down pointing triangle said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma ...

Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that ...

Bayer has agreed terms for its first biopharma acquisition in years, paying $300 million upfront for privately-held US biotech Perfuse Therapeutic and its novel drug implant for eye diseases. The deal ...

While pesticides are making us sick, corporations like Bayer are seeking immunity from lawsuits over harms linked to their products. Their efforts are failing. While pesticides are making us sick, ...

The US Supreme Court gave Bayer AG a mixed reception on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labeled as a cancer risk. Hearing arguments in ...

This is the first in a three-part series on Bayer’s crusade for immunity from Roundup-related cancer claims, published in partnership with the Center for Media and Democracy. Read the second and third ...

Oral argument set for Monday in Bayer case seeking to block pesticide lawsuits New federal lobbying declaration records released last night reveal that Bayer ramped up federal lobbying in Q1 2026, ...